1288372

Exeltis Pharmaceuticals, Inc. — FEI 3036871012

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 3, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tekirdag (Turkey)

Additional Details

Bioanalytical BA/BE